To present a case of renal cell carcinoma with KIF5B-ALK fusion and enhance understanding of this rare subtype's clinical significance.
Key Findings:
The patient had a renal tumor measuring 2.8 × 2.7 × 2.6 cm with atypical morphology.
Immunohistochemistry demonstrated renal epithelial differentiation and excluded other entities.
KIF5B-ALK gene fusion was confirmed through next-generation sequencing, indicating a specific oncogenic mechanism.
Interpretation:
The findings contribute to the clinical and pathological understanding of ALK-RCC, highlighting its rarity and the challenges in management due to limited treatment options, suggesting a need for targeted therapies.
Limitations:
The study is based on a single case report, limiting generalizability.
Limited data on the clinical outcomes and treatment responses for ALK-RCC, with potential biases in case selection.
Conclusion:
This case illustrates the characteristics of a rare subtype of ALK-RCC with KIF5B-ALK fusion, emphasizing the need for further research into its management and potential therapeutic strategies.
